John L. Brottem Sells 32,930 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem sold 32,930 shares of Outset Medical stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total transaction of $26,344.00. Following the transaction, the general counsel now directly owns 181,188 shares in the company, valued at $144,950.40. This represents a 15.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Outset Medical Stock Performance

Outset Medical stock traded down $0.03 during mid-day trading on Wednesday, reaching $0.78. 951,459 shares of the company’s stock were exchanged, compared to its average volume of 2,184,304. The business’s fifty day simple moving average is $1.01 and its 200 day simple moving average is $1.28. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a one year low of $0.44 and a one year high of $5.22. The firm has a market capitalization of $40.98 million, a PE ratio of -0.28 and a beta of 2.05.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a research report on Tuesday, January 7th.

Institutional Investors Weigh In On Outset Medical

Hedge funds have recently made changes to their positions in the business. Vanguard Personalized Indexing Management LLC bought a new position in Outset Medical during the second quarter valued at about $49,000. National Bank of Canada FI boosted its stake in Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after acquiring an additional 23,164 shares during the last quarter. Huntington National Bank boosted its stake in Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after acquiring an additional 20,000 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Outset Medical during the 2nd quarter valued at approximately $259,000. Finally, Squarepoint Ops LLC increased its stake in shares of Outset Medical by 74.1% during the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after purchasing an additional 34,187 shares during the last quarter.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.